Sonus Pharmaceuticals Inc - Current report filing (8-K)
March 05 2008 - 4:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported)
March 5, 2008
SONUS PHARMACEUTICALS, INC.
(Exact name of
Registrant as Specified in Its Charter)
Delaware
|
|
000-21243
|
|
95-4343413
|
(State or other jurisdiction
|
|
(Commission
|
|
(IRS Employer
|
of incorporation)
|
|
File Number)
|
|
Identification No)
|
1522 217
th
Place S.E.,
Bothell, Washington 98021
(Address of principal executive offices)
(425) 487-9500
(Registrants telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
o
|
Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
|
|
|
o
|
Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
|
|
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Item
2.02.
Results of Operations and
Financial Condition.
On
March 5, 2008, Sonus Pharmaceuticals, Inc. issued a press release
announcing its financial results for the fiscal year ended December 31,
2007. A copy of the press release making
this announcement is attached hereto as Exhibit 99.1, and is incorporated
herein by reference. The press release
shall not be deemed filed for purposes of Section 18 of the Securities
Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing
under the Securities Act of 1933.
Item
9.01
Financial Statements and
Exhibits.
(d)
Exhibits.
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press Release, dated March 5, 2008, issued by
Sonus Pharmaceuticals, Inc.
|
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
SONUS PHARMACEUTICALS, INC.
|
|
|
|
|
|
|
Date: March 5,
2008
|
By:
|
/s/
Alan Fuhrman
|
|
|
Alan
Fuhrman
|
|
|
Senior
Vice President and Chief Financial Officer
|
3
Exhibit Index
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press Release, dated March 5, 2008, issued by
Sonus Pharmaceuticals, Inc.
|
Sonus (NASDAQ:SNUS)
Historical Stock Chart
From Apr 2024 to May 2024
Sonus (NASDAQ:SNUS)
Historical Stock Chart
From May 2023 to May 2024